Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Monitoring drug resistance in leishmaniasis.

Tropical medicine & international health : TM & IH - 1 Nov 2001

Croft S L

Abstract excerpt

There are many factors that can influence the efficacy of drugs in the treatment of leishmaniasis. These include both an intrinsic variation in the sensitivity of Leishmania species, described for pentavalent antimonials, paromomycin, azoles and other drugs that have reached clinical trials, as well as acquired drug resistance to antimonials. Acquired resistance has been studied in the laboratory for several...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiprotozoal Agents
Share to Dose-Response Relationship, Drug
Share to Drug Resistance

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunocompetence

Share to Leishmania

Share to Leishmaniasis

Share to Parasitic Sensitivity Tests

Share to Species Specificity

Source

Identifiers

PMID: 11703844
DOI: 10.1046/j.1365-3156.2001.00754.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monitoring drug resistance in leishmaniasis.PMID 11703844Read ↗

Epidemiological Insights: Unraveling Drug Resistance in Leishmania Species through Comprehensive StudiesSemantic proximity Read ↗

Experimental Induction of Paromomycin Resistance in Antimony-Resistant Strains of L. donovani: Outcome Dependent on In Vitro Selection ProtocolSemantic proximity Read ↗

Impact of Genetic Diversity and Genome Plasticity of Leishmania spp. in Treatment and the Search for Novel Chemotherapeutic Targets.Semantic proximity Read ↗

Amphotericin B resistance in Leishmania amazonensis: In vitro and in vivo characterization of a Brazilian clinical isolateSemantic proximity Read ↗

Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs.Semantic proximity Read ↗

Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background.Semantic proximity Read ↗

Resistance to antimalarial compounds: methods and applications.Semantic proximity Read ↗

Experimental studies on the evolution of antimony-resistant phenotype during the in vitro life cycle of Leishmania infantum: implications for the spread of chemoresistance in endemic areas.Semantic proximity Read ↗

Drug sensitivity of Leishmania species: some unresolved problemsSemantic proximity Read ↗

Genomic characterization of Leishmania (V.) braziliensis associated with antimony therapeutic failure and variable in vitro tolerance to amphotericin BSemantic proximity Read ↗

Comparative Fitness of a Parent Leishmania donovani Clinical Isolate and Its Experimentally Derived Paromomycin-Resistant StrainSemantic proximity Read ↗

Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.